Health and Human Services Secretary Delegates Authority to NIH and FDA for Rare Neurodegenerative Diseases Partnership

Summary

The Secretary of Health and Human Services has delegated authority to the NIH Director and FDA Commissioner to establish and implement a Public-Private Partnership for rare neurodegenerative diseases, as mandated by the Accelerating Access to Critical Therapies for ALS Act, under Section 3.